ALX ONCOLOGY HOLDINGS INC
Ticker: 1810182
values in millions
| Period | Q2 FY20 |
|---|---|
| INCOME | |
| Revenue | 0.53 |
| Total Income | 0.53 |
| EXPENSES | |
| Expenditure | 11.31 |
| Tax | 0.02 |
| PROFIT | |
| PBT | -11.31 |
| Net Profit | -11.33 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -100.00% |
Corporate Events
Board MeetingALXO
202630Jun
Board Meeting
Scott Garland appointed Chairman of the Board, replacing Cor…
SEC Filing ↗ Board MeetingALXO
202610Jun
Board Meeting
Annual Meeting of stockholders to elect directors, approve e…
SEC Filing ↗ Board MeetingALXO
202613Apr
Board Meeting
Jeff Knight appointed as Chief Development and Operating Off…
SEC Filing ↗